Keyphrases
Opioid Antagonist
100%
Combinatorial Library
71%
Structure-activity Relationship
70%
Piperidine
65%
Interleukin-1β
58%
Dimethyl
56%
Opioid Receptors
54%
Nonapeptides
52%
Benzamide
51%
Methyl
49%
Amides
49%
Novel Class
47%
Chemical Library
47%
Resin
46%
Synthon
46%
Converting Enzyme
42%
ATP Citrate Lyase
42%
P-hydroxyphenyl
38%
Total Synthesis
37%
Amino
36%
Bradykinin
36%
Library Synthesis
36%
Tyrosine
35%
Bradykinin B2 Receptor Antagonist
33%
Comprehensive Survey
33%
Solid-phase Synthesis
33%
Alkylation
31%
Linker
29%
Sterols
29%
Polymer Support
28%
Sulfamoyl
28%
Ketones
28%
Amino Acids
27%
Angiotensin-converting Enzyme Inhibitor (ACEi)
26%
Phenyl
25%
Potent Inhibitor
25%
Aurodox
25%
Gyrase B Inhibitor
25%
Annual Review
25%
Solid-phase Reagents
25%
Chiral Ligands
25%
Scavenger
25%
Annulation
25%
Aldehydes
25%
Active Sites
25%
Irreversible Inhibitor
25%
Dopamine
25%
Hydroxylase
25%
Citric Acid
25%
Inducible Nitric Oxide Synthase
25%
Pharmacology, Toxicology and Pharmaceutical Science
Structure Activity Relationship
85%
Receptor
78%
Carboxamide
77%
Opiate Receptor
60%
Narcotic Antagonist
57%
Opiate Agonist
55%
Piperidine
50%
Cannabinoid 2 Receptor Agonist
37%
Bradykinin B2 Receptor Antagonist
33%
Adenosine Triphosphate Citrate Synthase
33%
Bradykinin
31%
Amino Acid
30%
Dipeptidyl Carboxypeptidase
29%
Combinatorial Library
28%
Benzamide Derivative
28%
Pharmaceutical Chemistry
27%
Analgesic Agent
27%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Interleukin 1
25%
Hypolipemia
25%
Lactam
25%
Pharmacokinetics
24%
Proteinase
23%
Piperidine Derivative
22%
Benzamide
22%
Drug Development
21%
Aspartic Acid
21%
Sterol
19%
Candida Albicans
19%
Cannabinoid 2 Receptor
19%
Bradykinin Antagonist
18%
Calcium Ion
16%
Inflammatory Disease
16%
Prodrug
16%
Calpain 1
16%
Disorders of Mitochondrial Functions
16%
Drug Discovery
16%
Methyltransferase
16%
Receptor Agonist
16%
Piperazine Derivative
16%
Statine
16%
Delta Opiate Receptor Agonist
16%
Cysteine Proteinase
16%
Acetone
16%
Plasmepsin II
16%
Dopamine Beta Monooxygenase
16%
Mu Opiate Receptor Antagonist
16%
Cannabinoid
16%
IC50
15%
Lead Compound
15%